Pharmaceutical company GlaxoSmithKline is investing $50 million in a fund to support early-stage life sciences research in Canada.
The GSK Canada Life Sciences Innovation Fund will be managed by GSK in Canada. It is intended to develop life sciences commercialisation in Canada through the identification of early-stage strategic investment opportunities.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.